143 related articles for article (PubMed ID: 35791778)
21. Expression of SATB2, RUNX2, and SOX9 and possible osteoblastic and chondroblastic differentiation in chondroblastoma.
Toda Y; Yamamoto H; Iwasaki T; Ishihara S; Ito Y; Susuki Y; Kawaguchi K; Kinoshita I; Kiyozawa D; Yamada Y; Kohashi K; Kimura A; Fujiwara T; Setsu N; Endo M; Matsumoto Y; Nakashima Y; Mawatari M; Oda Y
Pathol Res Pract; 2023 Jan; 241():154239. PubMed ID: 36442415
[TBL] [Abstract][Full Text] [Related]
22. Anti-histone H3.3K36M Antibody is a Highly Sensitive and Specific Immunohistochemistry Marker for the Diagnosis of Chondroblastoma. A Validation Based on Study 136 Cases Comprising Chondroblastoma and its Mimics from Single a Centre in India.
Hui M; Uppin SG; Narayanan R; Kancherla NR; Kamble A; B RR; Patnala C
Int J Surg Pathol; 2023 Jun; 31(4):375-386. PubMed ID: 35786027
[No Abstract] [Full Text] [Related]
23. Chondroblastoma-like osteosarcoma.
Martin KL; Firestone DE; McGarry SV; Dorfman HD; Kazmi SA
Pathol Int; 2014 Aug; 64(8):409-11. PubMed ID: 25143130
[No Abstract] [Full Text] [Related]
24. Aggressive curettage of a chondroblastoma-like osteosarcoma of the proximal end of the tibia. A case report with seven-year follow-up.
Ramos Pascua LR; Casas Ramos P; Arias Martín F; Izquierdo García FM
Skeletal Radiol; 2018 Jun; 47(6):853-857. PubMed ID: 29307095
[TBL] [Abstract][Full Text] [Related]
25. Chondromyxoid fibroma-like osteosarcoma: a distinct variant of low-grade osteosarcoma.
Chow LT; Lin J; Yip KM; Kumta SM; Ahuja AT; King WW; Lee JC
Histopathology; 1996 Nov; 29(5):429-36. PubMed ID: 8951487
[TBL] [Abstract][Full Text] [Related]
26. Utility of immunohistochemical expression of H3.3K36M and DOG1 in the diagnosis of chondroblastomas: An experience from a tertiary cancer referral center.
Rekhi B; Dave V; Butle A; Dutt A
Ann Diagn Pathol; 2023 Oct; 66():152174. PubMed ID: 37356274
[TBL] [Abstract][Full Text] [Related]
27. Histone 3.3 mutations in giant cell tumor and giant cell-rich sarcomas of bone.
Righi A; Mancini I; Gambarotti M; Picci P; Gamberi G; Marraccini C; Dei Tos AP; Simi L; Pinzani P; Franchi A
Hum Pathol; 2017 Oct; 68():128-135. PubMed ID: 28899740
[TBL] [Abstract][Full Text] [Related]
28. Epiphyseal osteosarcoma: distinguishing features from clear cell chondrosarcoma, chondroblastoma, and epiphyseal enchondroma.
Tsuneyoshi M; Dorfman HD
Hum Pathol; 1987 Jun; 18(6):644-51. PubMed ID: 3474206
[TBL] [Abstract][Full Text] [Related]
29. [The H3.3 K36M mutation protein expression of H3.3 in chondroblastoma: a novel diagnostic biomarker].
Gong LH; Zhang W; Dong RF; Zhang TT; Sun XQ; Zhang M; Ding Y
Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):242-244. PubMed ID: 33677889
[No Abstract] [Full Text] [Related]
30. Periosteal chondroblastoma of the femoral neck: two cases and a review of the literature.
Guillois C; Yang S; Biau D; Feydy A; Larousserie F
Skeletal Radiol; 2024 May; 53(5):1003-1009. PubMed ID: 37733062
[TBL] [Abstract][Full Text] [Related]
31. H3F3A G34 mutation DNA sequencing and G34W immunohistochemistry analysis in 366 cases of giant cell tumors of bone and other bone tumors.
Gong L; Bui MM; Zhang W; Sun X; Zhang M; Yi D
Histol Histopathol; 2021 Jan; 36(1):61-68. PubMed ID: 33021329
[TBL] [Abstract][Full Text] [Related]
32. Conventional chondrosarcoma with focal clear cell change: a clinicopathological and molecular analysis.
Lam SW; van Langevelde K; Suurmeijer AJH; Cleven AHG; Bovée JVMG
Histopathology; 2019 Dec; 75(6):843-852. PubMed ID: 31297850
[TBL] [Abstract][Full Text] [Related]
33. [Morphologic characteristics of chondroblastoma. A retrospective study of 56 cases of the Hamburg bone tumor register].
Pösl M; Amling M; Ritzel H; Werner M; Stenzel I; Delling G
Pathologe; 1996 Jan; 17(1):26-34. PubMed ID: 8685093
[TBL] [Abstract][Full Text] [Related]
34. H3F3A-mutated giant cell tumour of bone without giant cells-clinical presentation, radiology and histology of three cases.
Leinauer B; Wolf E; Werner M; Baumhoer D; Breining T; Luebke AM; Maas R; Schultheiß M; von Baer A; Sufi-Siavach A; Moritz C; Geißler S; Mellert K; Möller P; Barth TFE; Jundt G
Histopathology; 2021 Nov; 79(5):720-730. PubMed ID: 33991114
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical analysis of 36 cases of chondroblastomas: A single institutional experience.
Rekhi B; Ghate S; Shah A; Ramadwar M; Gulia A
Ann Diagn Pathol; 2020 Feb; 44():151440. PubMed ID: 31862519
[TBL] [Abstract][Full Text] [Related]
36. Chondroblastoma-like osteosarcoma: a case report and review.
Aycan OE; Vanel D; Righi A; Arikan Y; Manfrini M
Skeletal Radiol; 2015 Jun; 44(6):869-73. PubMed ID: 25492634
[TBL] [Abstract][Full Text] [Related]
37. Osteosarcoma with cytokeratin expression: a clinicopathological study of six cases with an emphasis on differential diagnosis from metastatic cancer.
Okada K; Hasegawa T; Yokoyama R; Beppu Y; Itoi E
J Clin Pathol; 2003 Oct; 56(10):742-6. PubMed ID: 14514776
[TBL] [Abstract][Full Text] [Related]
38. Mutation-driven epigenetic alterations as a defining hallmark of central cartilaginous tumours, giant cell tumour of bone and chondroblastoma.
Venneker S; Szuhai K; Hogendoorn PCW; Bovée JVMG
Virchows Arch; 2020 Jan; 476(1):135-146. PubMed ID: 31728625
[TBL] [Abstract][Full Text] [Related]
39. Chondroblastoma-like osteosarcoma.
Bacchini P; Inwards C; Biscaglia R; Picci P; Bertoni F
Orthopedics; 1999 Mar; 22(3):337-9. PubMed ID: 10192265
[No Abstract] [Full Text] [Related]
40. Chondroblastic osteosarcoma: Cytomorphologic characteristics and differential diagnosis on FNA.
VandenBussche CJ; Sathiyamoorthy S; Wakely PE; Ali SZ
Cancer Cytopathol; 2016 Jul; 124(7):493-500. PubMed ID: 26999748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
